Philip Morris CEO Jacek Olczak told the paper that the Marlboro brand will disappear from Britain over time.
Philip Morris International $PM plans to end selling cigarettes in the U.K. within ten years.
Philip Morris CEO Jacek Olczak told the Daily Mail that the cigarette maker's plan are part of its efforts to phase out traditional smoking in the country. Individuals who want to still smoke will be encouraged to switch to e-cigarettes or heated tobacco devices.
J
Just think guys IQOS has Smartphone connection capability. The possible smoking patterns data from IQOS could be/will be game changing. I use the product (switched from cigarettes) just like all my friends, it truly was a huge conversion in my country. PM is betting on a “healthier”, cheaper and better product, and I am as well!
w
It has been Britain's goal to be smoke free by 2030. Some of you on here must be unaware of their statement made years ago. They intend to be smoke free. PM sees the benefit to smoke-free and wants to further promote the "new" technology supported by science. PM desires that governments work to end all political groups stop stating erroneous information without recourse. These groups are spitting out misleading publicity regarding switching folks to alternative. Just today WHO is back attacking e-cigs and PM. PM is seeking full disclosure along with an end to "smoke" products that actually "smoke". The other groups have axes to grind and won't accept the new technology, no way or no how. Those groups should be silenced and allow science to prevail
R
I'm confused. Honestly. Why would a cigarette company pledge to stop selling cigarettes in the U.K.? Seriously, should I be selling my PM stock?
Must read my $HCMC Twitter thread showing that $PM IQOS product does have pyrolysis. Pyrolysis=combustion. I also found the FDA report for IQOS. Please share everywhere & like
I remember reading about a guy who traveled to Greece (I believe it was) a coupe of years ago. He was amazed at the number of people smoking the IQOS and their satisfaction with the product. .
Here is an article dated Dec. 2019 from a guy that traveled Europe and his experience meeting people who were very interested in his personal IQOS.
I think the use of IQOS world-wide is ready to bust wide open. I’ve smoked for 45 years and am using a vape to quit pretty successfully. I can’t wait for the IQOS.
I recently toured Europe and took this as an opportunity to explore IQOS in an active marketplace for Philip Morris.
I recently toured Europe and took this as an opportunity to explore IQOS in an active marketplace for Philip Morris.
seekingalpha.com
G
Good earnings, in a few quarters the forward P/E will be below 10. But I guess nobody cares about P/E anymore.
J
Research Alert: CFRA Maintains Buy Opinion On Shares Of Philip Morris International Inc. BY MT Newswires — 9:30 AM ET 07/20/2021
We raise our 12-month target by $5 to $110, based on a '22 P/E of 16.8x and a discount to its 5-year mean forward P/E of 17.8x. We maintain our '21 adjusted EPS estimate of $6.05 and raise '22 by $0.15 to $6.55.
r
Barrons today interviewed investment advisors mid year Roundtable. One of the advisors picks PM as a great investment thesis calling it the Tesla of tobacco with its IQOS Heat not burn product.
B
Goldman tobacco analyst liked the quarterly results. surprised this isn't higher. I bought a tiny bit for my account. I'll take +5% div yield +buyback +>10% earning growth, and foreign currency/inflation hedge built in. Thanks for the pull back.
G
US cigarette giant Philip Morris said Friday that it has agreed to buy Vectura, a UK company making breathing inhalers, as part of a push into healthcare
As part of its ambitious plans of building a smoke-free future, Philip Morris International Inc. PM agreed to acquire Fertin Pharma A/S, in a transaction worth approximately $820 million. Fertin Pharma is a leading manufacturer and developer of innovative pharmaceutical and well-being products that are based on oral and intra-oral delivery systems. Let’s take a closer look at the aspects associated with this buyout.
Benevolent Steps Toward Building a Smoke-Free Portfolio Philip Morris expects to complete the acquisition in fourth-quarter 2021, by funding the same through existing cash. On completion of the buyout, Fertin Pharma will become a wholly-owned subsidiary of Philip Morris. The acquisition is expected to be immaterial on Philip Morris’ full-year 2021 adjusted diluted earnings per share.
Fertin Pharma is a contract development and manufacturing organization, and is currently owned by the global investment organization EQT and Bagger-Sørensen & Co. This privately-held company’s operations are spread across Denmark, Canada and India. It specializes in research, development and production of gums, pouches, liquefiable tablets and other solid oral systems. The company’s operations are focused on the delivery of active ingredients, including nicotine. It is well-known for its unique Nicotine Replacement Therapy (NRT) solutions.
Both Philip Morris and Fertin Pharma share the common goal of delivering a smoke-free future and enable people to live healthier lives. Moreover, Philip Morris expects that Fertin Pharma’s superior scientific insights and technologies will enrich the company’s innovation capabilities, especially in the oral delivery platform. This is likely to aid in the formulation, development and commercialization of existing and additional smoke-free platforms. The company is likely to be able to accelerate presence in the fast-growing modern oral category, by providing a broad range of smoke-free products such as nicotine pouches and lozenges.
By leveraging Fertin Pharma’s technological capabilities, Philip Morris expects to develop scientifically substantiated botanicals and other selfcare wellness products including over-the-counter solutions and supplements in areas such as sleep, energy, calm and focus. Through this buyout, the company targets to expand offerings that are beyond nicotine. Apart from these, the company expects the acquisition to help broadening reach and access of their smoke-free alternatives to adult smokers around the world.
J
Imagine when people realize that not only: - Smoke-free (IQOS) tabacco has better margins and less of the harmfull effects - IQOS will have an app providding lots of consumer data -PM will OWN the Cannabis market (easy) -By replacing the market of ciggarets with IQOS, PM will have a world monopoly on tabacco.
Really planning to hold this for the next decade, and the dividend at 5% is almost like getting a rent on a property. love it
C
you people who attack companys for selling cigs ! it is you an your familys choice to smoke !! don,t blame them blame yourself for your own choices i have lost two uncles to lung cancer i know the risk but they lit ever cig that they smoked and it was there choice!
t
Healthier Choices Management Corp.(HCMC) today announced that, on July 26, 2021, the District Court for the Northern District of Georgia granted Philip Morris USA, Inc. and Philip Morris Products S.A.'s motion to dismiss HCMC's patent iffringement action against them. HCMC has fourteen days to file a motion for leave to file a further amended complaint, which HCMC intends to do by said deadline.
J
PM trading down $1.00 Pre market.
Beat: Earnings Flash (PM) PHILIP MORRIS INTERNATIONAL Posts Q2 EPS $1.57, vs. Street Est of $1.55. Miss: The company's net revenue increased 14% to $7.59 billion from $6.65 billion a year ago. According to FactSet, analysts were expecting $7.67 billion. EPS Lowered
J
Negative sentiment will keep the sharp price low and dividend high. Good for people who live off dividends
c
OMG, AWESOME earnings report. Dumbfounded at drop. Heck, that means they can buy back more shares at cheaper price.
m
My question for management is : There is a large audience of people who would like to smoke but do not want to be addicted . Offering a VLN version of a cigarette would accommodate that audience. And give this business a growth ingredient it has not had for years .
told the paper that the Marlboro brand will disappear from Britain over time.
Philip Morris International $PM plans to end selling cigarettes in the U.K. within ten years.
Philip Morris CEO Jacek Olczak told the Daily Mail that the cigarette maker's plan are part of its efforts to phase out traditional smoking in the country. Individuals who want to still smoke will be encouraged to switch to e-cigarettes or heated tobacco devices.
The possible smoking patterns data from IQOS could be/will be game changing.
I use the product (switched from cigarettes) just like all my friends, it truly was a huge conversion in my country.
PM is betting on a “healthier”, cheaper and better product, and I am as well!
https://twitter.com/BizWrld/status/1419109401680564224?s=19
I'm the 1st to find out $HCMC has 2 new patents. A laser vaporizer & a filter for vapes:
https://twitter.com/BizWrld/status/1419889720411131904?s=19
Here is an article dated Dec. 2019 from a guy that traveled Europe and his experience meeting people who were very interested in his personal IQOS.
I think the use of IQOS world-wide is ready to bust wide open. I’ve smoked for 45 years and am using a vape to quit pretty successfully. I can’t wait for the IQOS.
https://seekingalpha.com/article/4314651-iqos-trip-through-europe-and-why-philip-morris-is-buy
BY MT Newswires
— 9:30 AM ET 07/20/2021
We raise our 12-month target by $5 to $110, based on a '22 P/E of 16.8x and a discount to its 5-year mean forward P/E of 17.8x. We maintain our '21 adjusted EPS estimate of $6.05 and raise '22 by $0.15 to $6.55.
https://m.economictimes.com/news/international/business/tobacco-group-philip-morris-buys-maker-of-inhalers/amp_articleshow/84268470.cms?__twitter_impression=true
https://finance.yahoo.com/news/philip-morris-pm-boost-smoke-141202596.html
As part of its ambitious plans of building a smoke-free future, Philip Morris International Inc. PM agreed to acquire Fertin Pharma A/S, in a transaction worth approximately $820 million. Fertin Pharma is a leading manufacturer and developer of innovative pharmaceutical and well-being products that are based on oral and intra-oral delivery systems. Let’s take a closer look at the aspects associated with this buyout.
Benevolent Steps Toward Building a Smoke-Free Portfolio
Philip Morris expects to complete the acquisition in fourth-quarter 2021, by funding the same through existing cash. On completion of the buyout, Fertin Pharma will become a wholly-owned subsidiary of Philip Morris. The acquisition is expected to be immaterial on Philip Morris’ full-year 2021 adjusted diluted earnings per share.
Fertin Pharma is a contract development and manufacturing organization, and is currently owned by the global investment organization EQT and Bagger-Sørensen & Co. This privately-held company’s operations are spread across Denmark, Canada and India. It specializes in research, development and production of gums, pouches, liquefiable tablets and other solid oral systems. The company’s operations are focused on the delivery of active ingredients, including nicotine. It is well-known for its unique Nicotine Replacement Therapy (NRT) solutions.
Both Philip Morris and Fertin Pharma share the common goal of delivering a smoke-free future and enable people to live healthier lives. Moreover, Philip Morris expects that Fertin Pharma’s superior scientific insights and technologies will enrich the company’s innovation capabilities, especially in the oral delivery platform. This is likely to aid in the formulation, development and commercialization of existing and additional smoke-free platforms. The company is likely to be able to accelerate presence in the fast-growing modern oral category, by providing a broad range of smoke-free products such as nicotine pouches and lozenges.
By leveraging Fertin Pharma’s technological capabilities, Philip Morris expects to develop scientifically substantiated botanicals and other selfcare wellness products including over-the-counter solutions and supplements in areas such as sleep, energy, calm and focus. Through this buyout, the company targets to expand offerings that are beyond nicotine. Apart from these, the company expects the acquisition to help broadening reach and access of their smoke-free alternatives to adult smokers around the world.
- Smoke-free (IQOS) tabacco has better margins and less of the harmfull effects
- IQOS will have an app providding lots of consumer data
-PM will OWN the Cannabis market (easy)
-By replacing the market of ciggarets with IQOS, PM will have a world monopoly on tabacco.
Really planning to hold this for the next decade, and the dividend at 5% is almost like getting a rent on a property. love it
Beat: Earnings Flash (PM) PHILIP MORRIS INTERNATIONAL Posts Q2 EPS $1.57, vs. Street Est of $1.55.
Miss: The company's net revenue increased 14% to $7.59 billion from $6.65 billion a year ago. According to FactSet, analysts were expecting $7.67 billion.
EPS Lowered